标题
Pharmacokinetic characterization of favipiravir in patients with COVID‐19
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-01-11
DOI
10.1111/bcp.15227
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
- (2021) Tim Flerlage et al. NATURE REVIEWS MICROBIOLOGY
- Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
- (2021) Jean-Sélim Driouich et al. Nature Communications
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5′-triphosphate exposure to support posology for SARS-CoV-2
- (2021) Henry Pertinez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
- (2021) Soheil Hassanipour et al. Scientific Reports
- Population pharmacokinetics of favipiravir in patients with COVID‐19
- (2021) Kei Irie et al. CPT-Pharmacometrics & Systems Pharmacology
- Augmented renal clearance in critically ill COVID-19 patients: Forewarned is forearmed
- (2021) Sofie Dhaese et al. JOURNAL OF CRITICAL CARE
- Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score
- (2020) Dong Ji et al. CLINICAL INFECTIOUS DISEASES
- Dose Rationale for Favipiravir Use in Patients Infected With SARS‐CoV‐2
- (2020) Philippine Eloy et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection
- (2020) Yin‐Xiao Du et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID‐19
- (2020) Kei Irie et al. CTS-Clinical and Translational Science
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID‐19 (SARS‐COV‐2) treatments
- (2020) Emma H. Baker et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
- (2020) Nicolas Venisse et al. ANTIVIRAL RESEARCH
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted
- (2017) Thi Huyen Tram Nguyen et al. PLoS Neglected Tropical Diseases
- Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses
- (2016) Vincent Madelain et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started